BRADY MOFFETT to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications BRADY MOFFETT has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
1.421
-
Bioequivalence of enalapril oral solution for treatment of pediatric hypertension and enalapril tablets. Clin Pharmacol Drug Dev. 2014 11; 3(6):493-8.
Score: 0.400
-
Risk factors for postoperative acute kidney injury in pediatric cardiac surgery patients receiving angiotensin-converting enzyme inhibitors. Pediatr Crit Care Med. 2011 Sep; 12(5):555-9.
Score: 0.329
-
Future pharmacologic agents for treatment of heart failure in children. Pediatr Cardiol. 2006 Sep-Oct; 27(5):533-51.
Score: 0.232
-
National prescribing trends for heart failure medications in children. Congenit Heart Dis. 2015 Jan-Feb; 10(1):78-85.
Score: 0.099
-
Angiotensin-converting enzyme inhibitor nephrotoxicity in neonates with cardiac disease. Pediatr Cardiol. 2014 Mar; 35(3):499-506.
Score: 0.098
-
Hypotension as the etiology for angiotensin-converting enzyme (ACE) inhibitor-associated acute kidney injury in pediatric patients. Pediatr Cardiol. 2014 Jun; 35(5):767-70.
Score: 0.096
-
Response to intravenous potassium chloride supplementation in pediatric cardiac intensive care patients. Pediatr Cardiol. 2013 Apr; 34(4):887-92.
Score: 0.089
-
Captopril induced reversible acute renal failure in a premature neonate with double outlet right ventricle and congestive heart failure. World J Pediatr. 2011 Feb; 7(1):89-91.
Score: 0.078